Emergency type antiviral dry powder coating as well as preparation method and use method thereof

Through the use of emergency antiviral dry powder coatings, the use of steady-state sterilization and antiviral reagents and activators combined with silicon-based porous materials has solved the problems of attenuation and limitation of the antiviral effect of existing coatings, and achieved efficient indoor air sterilization and disinfection.

CN119019880APending Publication Date: 2024-11-26CHANGSHA BIAOLANG LIVING TECH CO LTD
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202411291835.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-14
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

The antiviral effect of existing sterilized and antiviral coatings gradually deteriorates after construction, and are only effective on the coating surface, and cannot effectively sterilize bacteria and viruses on the surface of indoor air and other objects.

Method used

An emergency antiviral dry powder coating is provided, including a steady-state sterilization and antiviral reagent powder and an activator. The antiviral reagent is activated by spraying an activator, and the sterilization and disinfection of the air is used to release sterilization components using silicon-based porous materials.

Benefits of technology

It has achieved stability and efficient sterilization and disinfection capabilities for a long time, and can actively attack bacteria and viruses in the air, change the traditional passive anti-viral mode, and ensure the safety of indoor air.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
Patent Text Reader

Abstract

The invention discloses an emergency antiviral dry powder coating as well as a preparation method and a use method thereof. The dry powder coating is prepared from a steady-state bactericidal antiviral agent, white carbon black, calcium carbonate, talcum powder, bentonite, cellulose, lignosulfonate, a silicon-based porous material, shell powder, mica powder, modified nano titanium dioxide, rubber powder and an activating agent. Preparing a steady-state bactericidal antiviral reagent and loading the steady-state bactericidal antiviral reagent in the silicon-based porous material; under the conditions of storage, construction and normal conditions, the antiviral reagent is in a steady state, when emergency requirements exist, only a small amount of activating agent needs to be sprayed in the air, the antiviral reagent is in an excited state after the activating agent is captured through diffusion and a silicon-based porous material, and antiviral gas can be continuously and stably released to the surface of a wall and the air; and bacteria and viruses existing in the environment can be effectively killed.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of coatings, and in particular to an emergency antiviral dry powder coating and a preparation method and a use method thereof. Background Art

[0002] With the acceleration of social and economic development, people have higher and higher requirements for indoor air quality. They are no longer satisfied with the decorative and aesthetic effects of paints, but have corresponding requirements for the functionality of paints. Influenced by the situation, the industry has proposed the concept of bactericidal and antiviral paints, but currently there are few paints that can effectively kill bacteria and antiviral.

[0003] The existing bactericidal and antiviral coatings have a short effective period of bactericidal and antiviral effects. The antiviral effect is best when it is just applied, and then the bactericidal and antiviral function gradually decays. For general home decoration and engineering coatings, it takes 3 to 6 months before people can move in. Secondly, the current bactericidal and antiviral coatings only have a bactericidal and antiviral effect on the coating surface, and have no effect on indoor air and bacteria and viruses on the surface of other objects. Therefore, how to achieve bactericidal and antiviral effects on indoor air is urgently needed. Summary of the invention

[0004] In view of this, the present invention provides an emergency antiviral dry powder coating. During storage, construction and normal conditions, the antiviral agent of the dry powder coating is in a steady state. When there is an emergency requirement, only a small amount of activator needs to be sprayed in the air or on the coating to activate the antiviral agent and release the antiviral active ingredients into the air to sterilize and disinfect the air.

[0005] To achieve the above object, the present invention adopts the following technical solutions:

[0006] An emergency antiviral dry powder coating comprises component A and component B, which comprises the following components by weight percentage:

[0007] Component A: steady-state bactericidal and antiviral agent powder 0.1-10%, white carbon black 1%-10%, silicon-based porous material 10-50%, calcium carbonate 1%-25%, talc 0.1%-10%, bentonite 0.1%-5%, cellulose 0.1-1%, lignin sulfonate 0.01-1%, shell powder 0.1%-15%, mica powder 0.1%-10%, modified nano titanium dioxide 0.1%-10%, rubber powder 5%-25%;

[0008] Component B: activator.

[0009] Preferably, the steady-state bactericidal and antiviral agent powder is prepared by the following process:

[0010] (1) mixing a silicon-based porous material with a particle size of 0.1-20 μm and potassium hydroxide evenly, placing the mixture in a vacuum furnace and calcining it at 600-800° C. for 30±5 min, cooling the mixture, grinding the mixture, and sieving the mixture to obtain a silicon-based porous material with a particle size of 0.1-20 μm;

[0011] (2) The steady-state bactericidal and antiviral agent is mixed evenly with the silicon-based porous material obtained in step (1) in a weight ratio of 1:2, 1-5 wt% of polyacrylic acid absorbent resin is added to the mixture to form a gel, the mixture is heated to 50 degrees Celsius for drying under nitrogen protection, taken out, cooled, ground, sieved, and a particle size of 0.1-20 μm is selected.

[0012] Preferably, the steady-state bactericidal and antiviral agent powder is one or more of trichloroisocyanuric acid, boric acid, and sodium bicarbonate.

[0013] Preferably, the white carbon black is fumed white carbon black.

[0014] Preferably, the calcium carbonate and talc are 500-800 mesh.

[0015] Preferably, the lignin sulfonate is one or more of sodium lignin sulfonate and calcium lignin sulfonate.

[0016] Preferably, the bentonite is sodium bentonite.

[0017] Preferably, the modified nano titanium dioxide is titanium dioxide having carboxyl and hydroxyl groups on the surface of grafted acrylic acid.

[0018] Preferably, the activator is baking soda with a mass concentration of 1%.

[0019] A method for using the emergency antiviral dry powder coating as described in the above technical solution is to mix component A and water in a weight ratio of 1:1 and apply it to the wall during coating construction; spray component B when antiviral is needed, and the spraying amount is 500mL per 25㎡.

[0020] A method for preparing the emergency antiviral dry powder coating as described in the above technical solution comprises the following processes:

[0021] First, the stable bactericidal and antiviral agent powder, bentonite, cellulose, lignin sulfonate, mica powder, modified nano titanium dioxide and 50% of the total weight of calcium carbonate are pre-mixed in a mixer at 50-60r / min for 1-2h to obtain a pre-mixed material; then, the remaining 50% of the total weight of calcium carbonate, 50% of the total weight of silicon-based porous materials, 50% of the total weight of white carbon black, 50% of the total weight of talcum powder, 50% of the total weight of shell powder, and 50% of the total weight of rubber powder are added to another mixer in sequence, and after stirring at 50-60r / min for 1h, the pre-mixed material and the remaining calcium carbonate, silicon-based porous materials, white carbon black, talcum powder, shell powder, and rubber powder are added and stirred at 50-60r / min for 2h to obtain component A; component A and component B can be packaged separately.

[0022] It can be seen from the above technical solution that, compared with the prior art, the present invention discloses an emergency antiviral dry powder coating that will not gradually decay with the extension of time after construction. When needed, the antiviral agent can be in an excited state through the diffusion of the activator and the capture of the silicon-based porous material, and has efficient bactericidal and antiviral performance; after the emergency antiviral dry powder coating is activated, the bactericidal and antiviral factors are released through the porous silicon-based material, which can actively attack bacteria and viruses in the air, changing the previous passive mode of antiviral coatings, and achieving true indoor sterilization and disinfection. DETAILED DESCRIPTION

[0023] The technical solution of the present invention will be clearly and completely described below in conjunction with the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0024] The various raw materials in the embodiments can be commercially available or prepared according to conventional methods in the art, which will not be described in detail here.

[0025] The stable bactericidal and antiviral agent powder is prepared by the following process:

[0026] (1) mixing a silicon-based porous material with a particle size of 0.1-20 μm and potassium hydroxide evenly, placing the mixture in a vacuum furnace and calcining it at 600-800° C. for 30±5 min, cooling the mixture, grinding the mixture, and sieving the mixture to obtain a silicon-based porous material with a particle size of 0.1-20 μm;

[0027] (2) The steady-state bactericidal and antiviral agent is mixed evenly with the silicon-based porous material obtained in step (1) in a weight ratio of 1:2, 1-5 wt% of polyacrylic acid absorbent resin is added to the mixture to form a gel, the mixture is heated to 50 degrees Celsius for drying under nitrogen protection, taken out, cooled, ground, sieved, and a particle size of 0.1-20 μm is selected.

[0028] Example 1

[0029] The emergency antiviral dry powder coating is composed of the following ingredients: 5% steady-state bactericidal and antiviral reagent powder, 7.5% white carbon black, 25% calcium carbonate, 5% talc, 1% bentonite, 0.55% cellulose, 0.05% lignin sulfonate, 12.5% ​​shell powder, 5% mica powder, 1.4% modified nano titanium dioxide, 27% silicon-based porous material, and 10% rubber powder.

[0030] Example 2

[0031] The emergency antiviral dry powder coating is composed of the following ingredients: 3% steady-state bactericidal and antiviral reagent powder, 7.5% white carbon black, 25% calcium carbonate, 5% talc, 1% bentonite, 0.55% cellulose, 0.05% lignin sulfonate, 12.5% ​​shell powder, 5% mica powder, 1.4% modified nano titanium dioxide, 29% silicon-based porous material, and 10% rubber powder.

[0032] Example 3

[0033] The emergency antiviral dry powder coating is composed of the following ingredients: 1% steady-state bactericidal and antiviral reagent powder, 7.5% white carbon black, 25% calcium carbonate, 5% talc, 1% bentonite, 0.55% cellulose, 0.05% lignin sulfonate, 12.5% ​​shell powder, 5% mica powder, 1.4% modified nano titanium dioxide, 31% silicon-based porous material, and 10% rubber powder.

[0034] Example 4

[0035] The emergency antiviral dry powder coating is composed of the following ingredients: 0% steady-state bactericidal and antiviral reagent powder, 7.5% white carbon black, 25% calcium carbonate, 5% talc, 1% bentonite, 0.55% cellulose, 0.05% lignin sulfonate, 12.5% ​​shell powder, 5% mica powder, 1.4% modified nano titanium dioxide, 32% silicon-based porous material, and 10% rubber powder.

[0036] The materials of Examples 1-4 above were prepared by the following process:

[0037] First, the stable bactericidal and antiviral agent powder, bentonite, cellulose, lignin sulfonate, mica powder, modified nano titanium dioxide and 50% of the total weight of calcium carbonate are pre-mixed in a mixer at 50-60r / min for 1-2h to obtain a pre-mixed material; then, the remaining 50% of the total weight of calcium carbonate, 50% of the total weight of silicon-based porous materials, 50% of the total weight of white carbon black, 50% of the total weight of talcum powder, 50% of the total weight of shell powder, and 50% of the total weight of rubber powder are added to another mixer in sequence, and after stirring at 50-60r / min for 1h, the pre-mixed material and the remaining calcium carbonate, silicon-based porous materials, white carbon black, talcum powder, shell powder, and rubber powder are added and stirred at 50-60r / min for 2h to obtain component A; component A and component B can be packaged separately.

[0038] When using, just mix component A and component B in proportion.

[0039] Test example

[0040] Performance test: The emergency antiviral dry powder coating of Example 1-4 and water were mixed evenly at a ratio of 1:0.75, and applied to a 100cm*100cm test board on one side. After curing, the board was placed in a sterilized and disinfected room at 1m 3 The indoor wall state was simulated in the experimental cabin, a sterilized glass plate was placed in the middle of the experimental cabin, and then a certain concentration of virus was atomized and injected into the experimental cabin, and then an equal amount of activator was added to the experimental cabin; sampling was carried out after 1 hour, and samples of the cabin gas and glass surface were collected for virus concentration testing. The test results are as follows:

[0041]

[0042]

[0043] As can be seen from the above table, Example 2 has the best antiviral effect and an acceptable odor, and the antiviral performance of Implementation Cases 1-3 is significantly improved compared to Implementation Case 4.

[0044] In this specification, each embodiment is described in a progressive manner, and each embodiment focuses on the differences from other embodiments. The same or similar parts between the embodiments can be referred to each other. For the device disclosed in the embodiment, since it corresponds to the method disclosed in the embodiment, the description is relatively simple, and the relevant parts can be referred to the method part.

[0045] The above description of the disclosed embodiments enables one skilled in the art to implement or use the present invention. Various modifications to these embodiments will be apparent to one skilled in the art, and the general principles defined herein may be implemented in other embodiments without departing from the spirit or scope of the present invention. Therefore, the present invention will not be limited to the embodiments shown herein, but rather to the widest scope consistent with the principles and novel features disclosed herein.

Claims

1. An emergency antiviral dry powder coating, characterized in that: It includes component A and component B, and includes the following components by weight percentage: Component A: steady-state bactericidal and antiviral agent powder 0.1-10%, white carbon black 1%-10%, silicon-based porous material 10-50%, calcium carbonate 1%-25%, talc 0.1%-10%, bentonite 0.1%-5%, cellulose 0.1-1%, lignin sulfonate 0.01-1%, shell powder 0.1%-15%, mica powder 0.1%-10%, modified nano titanium dioxide 0.1%-10%, rubber powder 5%-25%; Component B: activator.

2. The emergency antiviral dry powder coating according to claim 1, characterized in that: The stable bactericidal and antiviral agent powder is prepared by the following process: (1) mixing a silicon-based porous material with a particle size of 0.1-20 μm and potassium hydroxide evenly, placing the mixture in a vacuum furnace and calcining it at 600-800° C. for 30±5 min, cooling the mixture, grinding the mixture, and sieving the mixture to obtain a silicon-based porous material with a particle size of 0.1-20 μm; (2) The steady-state bactericidal and antiviral agent is mixed evenly with the silicon-based porous material obtained in step (1) in a weight ratio of 1:2, 1-5 wt% of polyacrylic acid absorbent resin is added to the mixture to form a gel, the mixture is heated to 50 degrees Celsius for drying under nitrogen protection, taken out, cooled, ground, sieved, and a particle size of 0.1-20 μm is selected.

3. The emergency antiviral dry powder coating according to claim 1, characterized in that: The stable bactericidal and antiviral agent powder is one or more of trichloroisocyanuric acid, boric acid and sodium bicarbonate.

4. The emergency antiviral dry powder coating according to claim 1, characterized in that: The calcium carbonate and talcum powder are 500-800 meshes.

5. The emergency antiviral dry powder coating according to claim 1, characterized in that: The lignin sulfonate is one or more of sodium lignin sulfonate and calcium lignin sulfonate.

6. The emergency antiviral dry powder coating according to claim 1, characterized in that: The bentonite is sodium bentonite.

7. The emergency antiviral dry powder coating according to claim 1, characterized in that: The modified nano titanium dioxide is titanium dioxide with carboxyl and hydroxyl groups on the surface of grafted acrylic acid.

8. The emergency antiviral dry powder coating according to claim 1, characterized in that: The activator is baking soda with a mass concentration of 1%.

9. A method for using the emergency antiviral dry powder coating according to any one of claims 1 to 9, characterized in that: During coating construction, mix component A and water in a weight ratio of 1:1 and apply it to the wall; when antiviral is needed, spray component B at a rate of 500 mL per 25 m2.

10. A method for preparing the emergency antiviral dry powder coating according to claims 1-9, characterized in that: Including the following processes: First, the stable bactericidal and antiviral agent powder, bentonite, cellulose, lignin sulfonate, mica powder, modified nano titanium dioxide and 50% of the total weight of calcium carbonate are pre-mixed in a mixer at 50-60r / min for 1-2h to obtain a pre-mixed material; then, the remaining 50% of the total weight of calcium carbonate, 50% of the total weight of silicon-based porous materials, 50% of the total weight of white carbon black, 50% of the total weight of talcum powder, 50% of the total weight of shell powder, and 50% of the total weight of rubber powder are added to another mixer in sequence, and after stirring at 50-60r / min for 1h, the pre-mixed material and the remaining calcium carbonate, silicon-based porous materials, white carbon black, talcum powder, shell powder, and rubber powder are added and stirred at 50-60r / min for 2h to obtain component A; component A and component B can be packaged separately.

Citation Information

Patent Citations

  • Multifunctional negative-ion dry powder paint

    CN110204933A

  • Long-acting slow-release bactericidal antiviral coating and preparation method and application thereof

    CN111704816A

  • Long-acting antiviral coating and preparation method thereof

    CN118599349A